<DOC>
	<DOCNO>NCT01509001</DOCNO>
	<brief_summary>Aim : The purpose study compare effect glimepiride ( G ) metformin ( M ) vascular reactivity , haemostatic factor glucose lipid profile patient type 2 diabetes . Methods : A prospective study perform 20 uncontrolled patient previously treat dietary intervention . Participants randomize M ( 750 2500 mg/day ) G ( 1 8 mg/day ) therapy . After 4 month , patient crossed-over washout period alternative treatment additional 4-month period similar dosage schedule . - The following variable assess ( basal value ) 4 month treatment period : 1 . Hormonal metabolic determination : fasting plasma glucose , insulin , catecholamine , lipid profile HbA1 level . 2 . Haemostatic factor : t-PA antigen activity , PAI-1 antigen activity , platelet aggregation , fibrinogen plasminogen level . 3 . Cardiovascular evaluation : flow index carotid brachial artery . Also , end treatment period , 12-hour metabolic profile include measurement glucose , insulin , glucagon , proinsulin triglyceride level fast every 2 hour ( 7:00 7:00 pm ) do</brief_summary>
	<brief_title>Study Metabolic Haemodynamic Effects Metformin Glimepiride Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description>Measurements make fast</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Glimepiride</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>type 2 diabetes patient fast glucose value &gt; 7.78 mmol/L and/or glycated hemoglobin exceed 1.0 % normal range ( 48.5 % ) 2 month diet therapy severe concomitant illness nephropathy ( serum creatinine &gt; 1.6 mg/dL microalbuminuria ) uncontrolled hypertension ( BP &gt; 190x120 mmHg ) stroke peripheral vascular disease mark dyslipidemia ( total cholesterol &gt; 6.5mM/L triglyceride level &gt; 2.8mM/L ) coagulopathy proliferative retinopathy use hypolipemic anticoagulant medication autonomic neuropathy assess blood pressure response stand beatto beat heart rate variation Valsalva maneuver handgrip test .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>type 2 diabetes</keyword>
	<keyword>metformin</keyword>
	<keyword>glimepiride</keyword>
	<keyword>glucose control</keyword>
	<keyword>vascular reactivity</keyword>
	<keyword>Adverse Reaction Other Drugs Medicines</keyword>
</DOC>